EDWARDS LIFESCIENCES CORP (EWL.DE) Fundamental Analysis & Valuation

FRA:EWL • US28176E1082

69.99 EUR
-2.51 (-3.46%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This EWL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Taking everything into account, EWL scores 7 out of 10 in our fundamental rating. EWL was compared to 65 industry peers in the Health Care Equipment & Supplies industry. EWL gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, EWL is valued expensive at the moment. These ratings would make EWL suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. EWL.DE Profitability Analysis

1.1 Basic Checks

  • In the past year EWL was profitable.
  • In the past year EWL had a positive cash flow from operations.
  • Each year in the past 5 years EWL has been profitable.
  • Each year in the past 5 years EWL had a positive operating cash flow.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • With an excellent Return On Assets value of 7.84%, EWL belongs to the best of the industry, outperforming 86.15% of the companies in the same industry.
  • EWL has a better Return On Equity (10.38%) than 66.15% of its industry peers.
  • The Return On Invested Capital of EWL (12.01%) is better than 84.62% of its industry peers.
  • EWL had an Average Return On Invested Capital over the past 3 years of 13.04%. This is above the industry average of 10.72%.
Industry RankSector Rank
ROA 7.84%
ROE 10.38%
ROIC 12.01%
ROA(3y)18.26%
ROA(5y)18.16%
ROE(3y)24.41%
ROE(5y)25.04%
ROIC(3y)13.04%
ROIC(5y)15.54%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 17.69%, EWL belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
  • In the last couple of years the Profit Margin of EWL has remained more or less at the same level.
  • The Operating Margin of EWL (27.17%) is better than 92.31% of its industry peers.
  • In the last couple of years the Operating Margin of EWL has declined.
  • EWL has a better Gross Margin (78.01%) than 90.77% of its industry peers.
  • In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
Industry RankSector Rank
OM 27.17%
PM (TTM) 17.69%
GM 78.01%
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. EWL.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
  • The number of shares outstanding for EWL has been reduced compared to 1 year ago.
  • Compared to 5 years ago, EWL has less shares outstanding
  • The debt/assets ratio for EWL has been reduced compared to a year ago.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 11.12 indicates that EWL is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of EWL (11.12) is better than 93.85% of its industry peers.
  • EWL has a debt to FCF ratio of 0.45. This is a very positive value and a sign of high solvency as it would only need 0.45 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.45, EWL belongs to the top of the industry, outperforming 95.38% of the companies in the same industry.
  • EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • EWL has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. EWL outperforms 90.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.45
Altman-Z 11.12
ROIC/WACC1.22
WACC9.85%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • EWL has a Current Ratio of 3.72. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.72, EWL belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • EWL has a Quick Ratio of 3.09. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of EWL (3.09) is better than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 3.72
Quick Ratio 3.09
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. EWL.DE Growth Analysis

3.1 Past

  • EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.29%.
  • Measured over the past 5 years, EWL shows a small growth in Earnings Per Share. The EPS has been growing by 6.67% on average per year.
  • Looking at the last year, EWL shows a quite strong growth in Revenue. The Revenue has grown by 10.86% in the last year.
  • The Revenue has been growing slightly by 6.70% on average over the past years.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%

3.2 Future

  • EWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.89% yearly.
  • EWL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.72% yearly.
EPS Next Y17.7%
EPS Next 2Y14.8%
EPS Next 3Y14.07%
EPS Next 5Y12.89%
Revenue Next Year10.66%
Revenue Next 2Y10.22%
Revenue Next 3Y10.13%
Revenue Next 5Y9.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. EWL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 31.67, the valuation of EWL can be described as expensive.
  • EWL's Price/Earnings is on the same level as the industry average.
  • EWL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.29.
  • The Price/Forward Earnings ratio is 26.85, which means the current valuation is very expensive for EWL.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EWL is on the same level as its industry peers.
  • EWL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.60.
Industry RankSector Rank
PE 31.67
Fwd PE 26.85
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • EWL's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. EWL is more expensive than 61.54% of the companies in the same industry.
  • EWL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 35.2
EV/EBITDA 23.31
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of EWL may justify a higher PE ratio.
  • EWL's earnings are expected to grow with 14.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.79
PEG (5Y)4.75
EPS Next 2Y14.8%
EPS Next 3Y14.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EWL.DE Dividend Analysis

5.1 Amount

  • No dividends for EWL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EWL.DE Fundamentals: All Metrics, Ratios and Statistics

EDWARDS LIFESCIENCES CORP

FRA:EWL (3/6/2026, 7:00:00 PM)

69.99

-2.51 (-3.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)04-21
Inst Owners91.12%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap40.65B
Revenue(TTM)6.07B
Net Income(TTM)1.07B
Analysts79.53
Price Target81.61 (16.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.39%
Min EPS beat(2)-8.84%
Max EPS beat(2)9.63%
EPS beat(4)3
Avg EPS beat(4)2.32%
Min EPS beat(4)-8.84%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)1.48%
EPS beat(12)5
Avg EPS beat(12)0.35%
EPS beat(16)7
Avg EPS beat(16)-0.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-1.47%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.84%
Revenue beat(12)2
Avg Revenue beat(12)-2.11%
Revenue beat(16)2
Avg Revenue beat(16)-2.28%
PT rev (1m)-1.5%
PT rev (3m)-0.09%
EPS NQ rev (1m)5.87%
EPS NQ rev (3m)6.38%
EPS NY rev (1m)1.35%
EPS NY rev (3m)2.47%
Revenue NQ rev (1m)1.79%
Revenue NQ rev (3m)1.48%
Revenue NY rev (1m)0.85%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 31.67
Fwd PE 26.85
P/S 7.75
P/FCF 35.2
P/OCF 29.46
P/B 4.55
P/tB 6.32
EV/EBITDA 23.31
EPS(TTM)2.21
EY3.16%
EPS(NY)2.61
Fwd EY3.72%
FCF(TTM)1.99
FCFY2.84%
OCF(TTM)2.38
OCFY3.39%
SpS9.04
BVpS15.4
TBVpS11.08
PEG (NY)1.79
PEG (5Y)4.75
Graham Number27.67
Profitability
Industry RankSector Rank
ROA 7.84%
ROE 10.38%
ROCE 13.87%
ROIC 12.01%
ROICexc 18.64%
ROICexgc 29.98%
OM 27.17%
PM (TTM) 17.69%
GM 78.01%
FCFM 22%
ROA(3y)18.26%
ROA(5y)18.16%
ROE(3y)24.41%
ROE(5y)25.04%
ROIC(3y)13.04%
ROIC(5y)15.54%
ROICexc(3y)18.54%
ROICexc(5y)20.56%
ROICexgc(3y)28.25%
ROICexgc(5y)29.44%
ROCE(3y)15.07%
ROCE(5y)17.95%
ROICexgc growth 3Y0.42%
ROICexgc growth 5Y-1.8%
ROICexc growth 3Y-6.11%
ROICexc growth 5Y-3.98%
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.45
Debt/EBITDA 0.33
Cap/Depr 166.16%
Cap/Sales 4.29%
Interest Coverage 81.62
Cash Conversion 88.36%
Profit Quality 124.36%
Current Ratio 3.72
Quick Ratio 3.09
Altman-Z 11.12
F-Score6
WACC9.85%
ROIC/WACC1.22
Cap/Depr(3y)177.3%
Cap/Depr(5y)193.25%
Cap/Sales(3y)4.93%
Cap/Sales(5y)5.41%
Profit Quality(3y)58.49%
Profit Quality(5y)66.28%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y17.7%
EPS Next 2Y14.8%
EPS Next 3Y14.07%
EPS Next 5Y12.89%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
Revenue Next Year10.66%
Revenue Next 2Y10.22%
Revenue Next 3Y10.13%
Revenue Next 5Y9.72%
EBIT growth 1Y11.04%
EBIT growth 3Y1.54%
EBIT growth 5Y4.82%
EBIT Next Year25.88%
EBIT Next 3Y16.1%
EBIT Next 5Y14.45%
FCF growth 1Y413.66%
FCF growth 3Y11.88%
FCF growth 5Y15.59%
OCF growth 1Y194.16%
OCF growth 3Y9.4%
OCF growth 5Y8.64%

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 31.67 and the Price/Book (PB) ratio is 4.55.